Status
Conditions
Treatments
About
The purpose of this study is to characterize changes in quality of life in patients who had undergone parathyroidectomy for secondary hyperparathyroidism due to end-stage renal disease, based on data extracted from an established database
Full description
Data were retrospectively collected from an established database of patients who underwent surgery for renal secondary hyperparathyroidism (SHPT). Extracted information included demographic and clinical characteristics (age, gender, education level, clinical symptoms), baseline quality of life assessed by the 36-item Short-Form Health Survey (SF-36), and completed follow-up assessments of SF-36 scores, depression, and anxiety at one, three, six months, and one year postoperatively.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Age ≥18 years; Patients who had undergone parathyroidectomy for secondary hyperparathyroidism due to end-stage renal disease.
Exclusion criteria
Patients who underwent kidney transplantation during the study period. Patients with postoperative whole blood parathyroid hormone levels >300 pg/mL within the first week after surgery.
Patients with missing postoperative quality of life assessment data.
60 participants in 1 patient group
Loading...
Central trial contact
Chunling Jiang, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal